Equity Analysis

Quarterly Results

    Bacil Pharma Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs
    BSE Code
    ISIN Demat
    Book Value()
    524516
    INE711D01018
    1.7864177
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    N.A
    65.58
    25.11
    EPS(TTM)
    Face Value()
    Div & Yield %:
    0.65
    10
    0
     
Quarters
(RupeeIcon Cr)
ParticularsDec 2024Sep 2024Jun 2024
Gross Sales0.000.000.00
Other Operating Income0.000.000.00
Other Income 0.000.560.01
Total Income0.000.560.01
Total Expenditure 0.060.070.04
PBIDT-0.060.49-0.03
Interest 0.000.000.00
PBDT-0.060.49-0.03
Depreciation0.000.000.00
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax0.000.000.00
Reported Profit After Tax-0.060.48-0.03
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-0.060.48-0.03
EPS (Unit Curr.)-0.100.82-0.06
EPS (Adj) (Unit Curr.)-0.100.82-0.06
Calculated EPS (Unit Curr.)-0.100.82-0.06
Calculated EPS (Adj) (Unit Curr.)-0.100.82-0.06
Calculated EPS (Ann.) (Unit Curr.)-0.423.29-0.23
Calculated EPS (Adj) (Ann.) (Unit Curr.)-0.423.29-0.23
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity5.895.895.89
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)0.000.000.00
PBDTM(%)0.000.000.00
PATM(%)0.000.000.00
Dividend Per Share(Rs)0.000.000.00
Diluted EPS-0.100.82-0.06